通过增强粘膜透,通过响应性微针贴片局部治疗口腔
Junhua Xu1, Haochen Wang2, Kaizhi Li1
1Institute of Biopharmaceutics, West China Hospital, Sichuan University, Chengdu, Sichuan, PR China.
International journal of pharmaceutics
|January 20, 2026
概括
新的微针贴片将德克萨米他直接输送到口腔上. 这种有针对性的方法通过释放药物来应对状况来增强愈合并减少炎症,从而改善治疗结果.
科学领域:
- 生物材料科学 生物材料科学
- 药物输送系统 药物输送系统
- 口腔医学是指口腔医学.
背景情况:
- 口腔是痛苦和常见的,当前的治疗方法,如局部德甲面临药物透和全身副作用的挑战.
- 对口腔粘膜病变有效局部递送皮质类固醇仍然是一个重要的临床需求.
研究的目的:
- 开发和评估一种新型溶解微针贴片,用于局部口服递送甲,封装在蛋白酶响应的等纳米颗粒 (DEX@GNPs) 中.
- 在口腔模型中评估该系统在增强药物沉积,减少大小,促进再生和减轻炎症方面的有效性.
主要方法:
- 开发DEX@GNP,并将其纳入溶解微针贴片中.
- 在老鼠口腔模型中评估微针透和药物释放特征.
- 通过测量的大小,组织再生和促炎性细胞因子水平来评估治疗疗效.
主要成果:
- 装有DEX@GNP的微针成功地将德甲输送到口腔粘膜层.
- 观察到的显著减少大小和促进组织再生.
- 作为对蛋白酶水平升高的反应,响应性德克萨米他释放导致炎症减少和较低的炎症性细胞因子水平.
结论:
- 装有DEX@GNP的微针贴片为局部治疗口腔提供了一个有希望的策略.
- 这种方法促进了高效的皮质类固醇输送,可能改善治疗结果和患者管理.
相关概念视频
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
1.2K
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.2K
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
1.4K
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
1.4K
Drugs for Treatment of Ulcerative Colitis in IBD
468
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
468
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
1.1K
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
1.1K
Mucosal Barrier of the Stomach
2.1K
The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl.
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
2.1K
Long-patch Base Excision Repair
7.9K
Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
7.9K


